Market Overview:
The global MMR vaccines market is expected to grow at a CAGR of 9.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as rising incidence of measles, increasing demand for combination vaccines, and growing awareness about the benefits of MMR vaccination. Based on type, the global MMR vaccines market is segmented into monovalent, combinational, divalent, and trivalent vaccines. The monovalent vaccine segment is expected to account for the largest share of the global MMR vaccines market in 2018. This segment is projected to grow at a CAGR of 10% during the forecast period from 2018 to 2030. This growth can be attributed to rising demand for single-dose monovalent measles vaccine formulations and increasing incidence of measles worldwide. Based on application, the global MMR vaccines market is divided into pediatric applications (0-17 years), adolescent applications (18-23 years), adult applications (24-59 years), and elderly applications (>60 years).
Product Definition:
MMR vaccines are a combination vaccine that protects against three diseases: measles, mumps, and rubella. It is usually given to children in two doses: the first dose at 12 to 15 months old and the second dose at 4 to 6 years old. The MMR vaccine is very important because it helps protect children from these serious diseases.
Monovalent:
Monovalent vaccines are those used for the prevention of a single disease. They are different from bivalent and trivalent vaccines as they target and protect against a single virus, rather than two or more viruses in combination. Monovalent vaccines can be administered to individuals without previous immunization owing to their higher efficacy.
Combinational:
Combinational medicines or vaccines involve the use of more than one drug or vaccine to treat a particular disease. For instance, the measles-mumps-rubella (MMR) vaccine is a combinatorial vaccine as it involves using three separate injections to stimulate the body’s immune system and protect against measles, mumps and rubella. Similarly, hepatitis B vaccination also involves using three shots over a period of six months.
Application Insights:
Adults application segment held the largest share of more than 50.0% in 2017. The growing geriatric population and increasing number of people with immune system disorders are the major factors driving the demand for measles vaccines in adults. According to data published by U.S Department of Health & Human Services, around 1,000 cases of measles were reported in 2015 which resulted in deaths Of about 21 million who received vaccine against this disease globally since 1963 till 2014 (Measles Vaccine: A Global Perspective).
The pediatric segment is expected to be fastest-growing at a CAGR 5.7% from 2018 to 2030 owing to rising awareness regarding immunization against a number of diseases particularly targeted vaccines.
Regional Analysis:
Asia Pacific dominated the market in 2017 and is expected to maintain its position during the forecast period. This can be attributed to increasing government initiatives, growing target population base, and rising incidence of measles. For instance, in December 2015, WHO launched an initiative called Measles & Rubella Initiative (MRI) with a focus on eliminating rubella and maternal mortality associated with it by 2020 through mass vaccination programs. In addition, Asia Pacific governments are continuously investing in research & development activities for developing new vaccines as well as improving existing immunization programs against major vaccine-preventable diseases such as measles/mumps/rubella (MMR).
In November 2016; India’s Department of Health launched a national immunization program against 12 major diseases including MMR along with other measures for tackling undernutrition among children aged 1-12 years. Moreover high prevalence of malnutrition has led to increased susceptibility towards infectious disease which needs immediate attention from public health authorities worldwide.
Growth Factors:
- Increasing incidence of measles and other MMR-preventable diseases: The global incidence of measles has decreased by 79% from 2000 to 2016. However, the disease still causes around 134,200 deaths each year. This number could be reduced significantly with increased uptake of MMR vaccines.
- Improved vaccine efficacy and safety: The latest version of the MMR vaccine (MMRV) is more efficacious and safer than earlier versions, thus increasing its uptake rates.
- Growing awareness about the benefits of vaccination: There is a growing awareness among parents about the importance of vaccinating their children against measles and other diseases preventable by MMR vaccines.
Scope Of The Report
Report Attributes
Report Details
Report Title
MMR Vaccines Market Research Report
By Type
Monovalent, Combinational, Divalent, Trivalent
By Application
Pediatrics, Adolescents, Adults, Elderly
By Companies
GlaxoSmithKline, Medlmmune, Merck, Sanofi Pasteur, Serum Institute, GlaxoSmithKline
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
204
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global MMR Vaccines Market Report Segments:
The global MMR Vaccines market is segmented on the basis of:
Types
Monovalent, Combinational, Divalent, Trivalent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pediatrics, Adolescents, Adults, Elderly
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Medlmmune
- Merck
- Sanofi Pasteur
- Serum Institute
- GlaxoSmithKline
Highlights of The MMR Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monovalent
- Combinational
- Divalent
- Trivalent
- By Application:
- Pediatrics
- Adolescents
- Adults
- Elderly
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the MMR Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
MMR vaccines are a series of shots that help protect people from measles, mumps, and rubella. These diseases can cause serious health problems, including pneumonia and even death. MMR vaccines are recommended for children between 12 months and 18 years old.
Some of the major players in the mmr vaccines market are GlaxoSmithKline, Medlmmune, Merck, Sanofi Pasteur, Serum Institute, GlaxoSmithKline.
The mmr vaccines market is expected to grow at a compound annual growth rate of 9.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 MMR Vaccines Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 MMR Vaccines Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 MMR Vaccines Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the MMR Vaccines Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global MMR Vaccines Market Size & Forecast, 2018-2028
4.5.1 MMR Vaccines Market Size and Y-o-Y Growth
4.5.2 MMR Vaccines Market Absolute $ Opportunity
Chapter 5 Global MMR Vaccines Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 MMR Vaccines Market Size Forecast by Type
5.2.1 Monovalent
5.2.2 Combinational
5.2.3 Divalent
5.2.4 Trivalent
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global MMR Vaccines Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 MMR Vaccines Market Size Forecast by Applications
6.2.1 Pediatrics
6.2.2 Adolescents
6.2.3 Adults
6.2.4 Elderly
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global MMR Vaccines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 MMR Vaccines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America MMR Vaccines Analysis and Forecast
9.1 Introduction
9.2 North America MMR Vaccines Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America MMR Vaccines Market Size Forecast by Type
9.6.1 Monovalent
9.6.2 Combinational
9.6.3 Divalent
9.6.4 Trivalent
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America MMR Vaccines Market Size Forecast by Applications
9.10.1 Pediatrics
9.10.2 Adolescents
9.10.3 Adults
9.10.4 Elderly
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe MMR Vaccines Analysis and Forecast
10.1 Introduction
10.2 Europe MMR Vaccines Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe MMR Vaccines Market Size Forecast by Type
10.6.1 Monovalent
10.6.2 Combinational
10.6.3 Divalent
10.6.4 Trivalent
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe MMR Vaccines Market Size Forecast by Applications
10.10.1 Pediatrics
10.10.2 Adolescents
10.10.3 Adults
10.10.4 Elderly
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific MMR Vaccines Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific MMR Vaccines Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific MMR Vaccines Market Size Forecast by Type
11.6.1 Monovalent
11.6.2 Combinational
11.6.3 Divalent
11.6.4 Trivalent
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific MMR Vaccines Market Size Forecast by Applications
11.10.1 Pediatrics
11.10.2 Adolescents
11.10.3 Adults
11.10.4 Elderly
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America MMR Vaccines Analysis and Forecast
12.1 Introduction
12.2 Latin America MMR Vaccines Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America MMR Vaccines Market Size Forecast by Type
12.6.1 Monovalent
12.6.2 Combinational
12.6.3 Divalent
12.6.4 Trivalent
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America MMR Vaccines Market Size Forecast by Applications
12.10.1 Pediatrics
12.10.2 Adolescents
12.10.3 Adults
12.10.4 Elderly
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) MMR Vaccines Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) MMR Vaccines Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) MMR Vaccines Market Size Forecast by Type
13.6.1 Monovalent
13.6.2 Combinational
13.6.3 Divalent
13.6.4 Trivalent
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) MMR Vaccines Market Size Forecast by Applications
13.10.1 Pediatrics
13.10.2 Adolescents
13.10.3 Adults
13.10.4 Elderly
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 MMR Vaccines Market: Competitive Dashboard
14.2 Global MMR Vaccines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Medlmmune
14.3.3 Merck
14.3.4 Sanofi Pasteur
14.3.5 Serum Institute
14.3.6 GlaxoSmithKline
